Asia-Pacific bronchiectasis market is projected to register a healthy CAGR of 6.5% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation
Asia-Pacific Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral and Inhalation), End User (Hospitals, Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam and Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of Asia-Pacific bronchiectasis market are:
Availability of generic drugs in underdeveloped and developing countries.
Rising patient population suffering from bronchiectasis.
Market Players
The key market players for the bronchiectasis market are listed below:
Abott
HERSILL
Inogen, Inc.
Boehringer Ingelheim International GmbH
Medline Industries, Inc
Ache Laboratories Farmaceuticos S.A.
Johnson & Johnson, Inc.
GlaxoSmithKline plc.
AstraZeneca
Pfizer Inc.
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Bayer AG
Dr. Reddys Laboratories Ltd.
Viatris Inc.
Cipla Inc.
TABLE OF CONTENT
Segmentation
Short Description
Asia-Pacific Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral and Inhalation), End User (Hospitals, Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam and Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Definition
Bronchiectasis is a condition which leads to damage of lungs airways that is infection and inflammation occurs in the path were air comes in and out. The mucus gets collected in the airways which get clogged and bacteria start to grow in that region which leads to bronchiectasis. When this mucus gets collected in the airways and is not early diagnosed and treated it may cause damage to the lungs. This condition mainly occurs in women population and in United States it was recorded that children with whooping cough generally have bronchiectasis.
Bronchiectasis can be congenital or acquired. The acquired one occurs mainly in infants and children whereas congenital occurs in adults. Cystic fibrosis, immunodeficiency disorders, allergic bronchopulmonary aspergillosis, and primary ciliary dyskinesia are some of the risk factors for bronchiectasis. Mainly antibiotics and oxygen therapies are recommended by the doctors and the patients have to live the condition as there is no permanent cure for the disease.
Market Segmentation
Bronchiectasis market is categorized into seven notable segments which are based on the basis of disease type, severity, type, drugs type, route of administration, end user, and distribution channel.
On the basis of disease type, the bronchiectasis market is segmented into non-CF bronchiectasis and CF bronchiectasis.
On the basis of severity, the bronchiectasis market is segmented into mild to moderate and moderate-to-severe.
On the basis of type, the bronchiectasis market is segmented into treatment and diagnosis.
On the basis of drugs type, the bronchiectasis market is segmented into branded and generics.
On the basis of route of administration, the bronchiectasis market is segmented into oral, parenteral, and inhalation.
On the basis of end user, the bronchiectasis market is segmented into hospitals, clinics, home healthcare, and others.
On the basis of distribution channel, the bronchiectasis market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.
Market Players
The key market players for the bronchiectasis market are listed below:
Abott
HERSILL
Inogen, Inc.
Boehringer Ingelheim International GmbH
Medline Industries, Inc
Ache Laboratories Farmaceuticos S.A.
Johnson & Johnson, Inc.
GlaxoSmithKline plc.
AstraZeneca
Pfizer Inc.
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Bayer AG
Dr. Reddys Laboratories Ltd.
Viatris Inc.
Cipla Inc.
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
